Status:
RECRUITING
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Diabetes in Pregnancy
Gestational Diabetes
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study a...
Detailed Description
Purpose/Specific Aims The purpose of this study is to determine if a single dose of long-acting insulin is non-inferior to long-acting insulin plus prandial insulin to manage diabetes in pregnancy, m...
Eligibility Criteria
Inclusion
- Diagnosed with type 2 diabetes mellitus or A2 gestational diabetes mellitus requiring insulin use during pregnancy
- Aged between 18-50
- Speak English or Spanish
Exclusion
- Pre-existing use of insulin
- Gestational Age \> or = 35w0d
- Planning to follow-up with a doctor not associated with RWJ Barnabas and/or deliver at a hospital other than RWJUH
- Unwilling or unable to upload or email weekly blood sugar logs
- Contraindication to Lispro or Lantus insulin, or patient chooses to not utilize insulin therapy
- Fetal anomaly present
Key Trial Info
Start Date :
November 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2027
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT07171684
Start Date
November 26 2025
End Date
May 15 2027
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Wood Johnson Univeristy Hospital
New Brunswick, New Jersey, United States, 08901